Trump announces tariff cuts with China after successful talks, signaling progress in trade negotiations.
Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
Trump announces tariff cuts with China after successful talks, signaling progress in trade negotiations.
Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.